These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22817559)

  • 1. Metaproterenol, isoproterenol, and their bisdimethylcarbamate derivatives as human cholinesterase inhibitors.
    Bosak A; Gazić Smilović I; Sinko G; Vinković V; Kovarik Z
    J Med Chem; 2012 Aug; 55(15):6716-23. PubMed ID: 22817559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral site and acyl pocket define selective inhibition of mouse butyrylcholinesterase by two biscarbamates.
    Bosak A; Smilović IG; Stimac A; Vinković V; Sinko G; Kovarik Z
    Arch Biochem Biophys; 2013 Jan; 529(2):140-5. PubMed ID: 23219600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Chem Biol Interact; 2008 Sep; 175(1-3):192-5. PubMed ID: 18582854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
    Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
    Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
    Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
    Więckowska A; Bajda M; Guzior N; Malawska B
    Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
    Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
    J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Wu J; Pistolozzi M; Liu S; Tan W
    Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
    Zhan ZJ; Bian HL; Wang JW; Shan WG
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
    Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proline-Based Carbamates as Cholinesterase Inhibitors.
    Pizova H; Havelkova M; Stepankova S; Bak A; Kauerova T; Kozik V; Oravec M; Imramovsky A; Kollar P; Bobal P; Jampilek J
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29135926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
    Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.